Centre Antoine Lacassagne

corporate_fareorganization

Centre Antoine Lacassagne

- Funding / Projects
  (56)

56 Projects, page 1 of 12

Adjuvant immunotherapy after salvage surgery in head and neck squamous cell carcinoma: phase 2 trial evaluating the efficacy and the toxicity of nivolumab alone, and of the combination of nivolumab and ipimilumab
assignment_turned_inProjectPartners:CHU, Centre Léon Bérard, Hôpital Foch, CHUG, Institut Jean Godinot +5 partners
CHU,
Centre Léon Bérard,
Hôpital Foch,
CHUG,
Institut Jean Godinot,
Hôpital Larrey -CHU Toulouse,
CHU Montpellier - Hôpital Gui de Chauliac,
Centre Antoine Lacassagne,
CHU Marseille - Hôpital la Timone,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-11181
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Radiation-induced sarcoma: predictive study based on the CONTICANET sarcomas registry.
assignment_turned_inProjectPartners:Centre Léon Bérard, Centre Antoine Lacassagne, Centre Paul Strauss, Groupe Hospitalier Henri Mondor - Albert Chenevier, CHU Marseille - Hôpital la Timone +5 partners
Centre Léon Bérard,
Centre Antoine Lacassagne,
Centre Paul Strauss,
Groupe Hospitalier Henri Mondor - Albert Chenevier,
CHU Marseille - Hôpital la Timone,
Centre Georges-François Leclerc,
Institut Gustave Roussy,
Centre Oscar Lambret,
Institut de Cancérologie de Lorraine,
INSERM U916
Funder: Institut National du Cancer Project Code: INCa-DGOS-3770
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Evaluation and validation of quality of life scales in palliative advance cancer Title of the study – Evaluation and validation of quality of life scales in palliative advance cancer.
assignment_turned_inProjectPartners:Centre Oscar Lambret, Centre Georges-François Leclerc, Institut Bergonié, Centre Hospitalier Universitaire d'Angers, Hôpital Jean Minjoz +7 partners
Centre Oscar Lambret,
Centre Georges-François Leclerc,
Institut Bergonié,
Centre Hospitalier Universitaire d'Angers,
Hôpital Jean Minjoz,
ICM-VAL D'AURELLE,
Centre François Baclesse,
Institut de Cancérologie de l'Ouest,
Institut Curie,
Hôpital Morvan,
Centre Antoine Lacassagne,
Centre Hospitalier de Cholet
Funder: Institut National du Cancer Project Code: INCa-DGOS-3764
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
EPIC-2015: Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers, treated with first-line chemotherapy: a randomized phase III trial
assignment_turned_inProjectPartners:Centre Antoine Lacassagne, Centre Oscar Lambret, Institut Bergonié, INSERM U1113, Centre Georges-François Leclerc +2 partners
Centre Antoine Lacassagne,
Centre Oscar Lambret,
Institut Bergonié,
INSERM U1113,
Centre Georges-François Leclerc,
Institut Paoli-Calmettes- (IPC),
Centre Léon Bérard
Funder: Institut National du Cancer Project Code: INCa-DGOS-11170
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.
assignment_turned_inProjectPartners:Centre François Baclesse, Institut Curie, Centre Eugène Marquis, Centre René Gauducheau, Institut Paoli-Calmettes- (IPC) +10 partners
Centre François Baclesse,
Institut Curie,
Centre Eugène Marquis,
Centre René Gauducheau,
Institut Paoli-Calmettes- (IPC),
Centre Hospitalier de Mont-de-Marsan,
Centre Antoine Lacassagne,
Clinique Sainte Marguerite,
Centre Léon Bérard,
Hôpital Saint-Louis,
Institut Jean Godinot,
Hôpital Saint Joseph,
Hôpital Édouard Herriot,
Institut Gustave Roussy,
Institut de Cancérologie de l'Ouest
Funder: Institut National du Cancer Project Code: INCa-DGOS-7193
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Centre Antoine Lacassagne

Centre Antoine Lacassagne

56 Projects, page 1 of 12

Adjuvant immunotherapy after salvage surgery in head and neck squamous cell carcinoma: phase 2 trial evaluating the efficacy and the toxicity of nivolumab alone, and of the combination of nivolumab and ipimilumab

Radiation-induced sarcoma: predictive study based on the CONTICANET sarcomas registry.

Evaluation and validation of quality of life scales in palliative advance cancer Title of the study – Evaluation and validation of quality of life scales in palliative advance cancer.

EPIC-2015: Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers, treated with first-line chemotherapy: a randomized phase III trial

GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.

Loading